{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:49:40Z","timestamp":1787993380208,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"German Joint Federal Committee","award":["01VSF16008"],"award-info":[{"award-number":["01VSF16008"]}]},{"name":"German Stifterverband"},{"name":"CORONA Foundation","award":["S199\/10061\/2015"],"award-info":[{"award-number":["S199\/10061\/2015"]}]},{"name":"German Joint Federal Committee","award":["01VSF18035"],"award-info":[{"award-number":["01VSF18035"]}]},{"DOI":"10.13039\/100004326","name":"Bayer Vital GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007534","name":"B. Braun Melsungen AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007534","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of the University Heart and Vascular Centre Hamburg"},{"name":"US Food and Drug Administration","award":["U01FD005478"],"award-info":[{"award-number":["U01FD005478"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejvs.2019.12.034","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:11:21Z","timestamp":1578499881000},"page":"587-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Editor's Choice \u2013 Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis"],"prefix":"10.1016","volume":"59","author":[{"given":"Christian-Alexander","family":"Behrendt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Art","family":"Sedrakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-8410","authenticated-orcid":false,"given":"Frederik","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Kreutzburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schermerhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bertges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-2022","authenticated-orcid":false,"given":"Axel","family":"Larena-Avellaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"L'Hoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike Sebastian","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2019.12.034_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2019.12.034_bib3","first-page":"e726","article-title":"AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.12.034_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2019.12.034_bib5","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.12.034_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jacc.2018.10.002","volume":"73","author":"Bailey","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib7","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2019.12.034_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1024\/0301-1526\/a000778","article-title":"Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic","volume":"48","author":"Zeller","year":"2019","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2019.12.034_bib10","first-page":"e42","article-title":"Correction to: durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery 5-year results of the Zilver PTX randomized trial","volume":"139","author":"Dake","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.12.034_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00772-018-0475-8","article-title":"International consortium of vascular registries","volume":"24","author":"Venermo","year":"2018","journal-title":"Gef\u00e4sschirurgie"},{"key":"10.1016\/j.ejvs.2019.12.034_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamacardio.2019.0339","article-title":"Assessing the long-term safety of endovascular therapies \u2013 the case of peripheral paclitaxel-coated devices","volume":"4","author":"Giri","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-017-0524-8","article-title":"Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis","volume":"16","author":"Freisinger","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib14","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","article-title":"Recent trends in morbidity and in-hospital outcomes\u00a0of in-patients with peripheral arterial disease: a nationwide population-based analysis","volume":"34","author":"Malyar","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2019.12.034_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12874-017-0407-4","article-title":"The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data","volume":"17","author":"Czwikla","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00103-008-0646-y","article-title":"[Validation of secondary data. Strengths and limitations]","volume":"51","author":"Hoffmann","year":"2008","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.ejvs.2019.12.034_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028223","article-title":"Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry","volume":"9","author":"Langner","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2019.12.034_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12889-015-1943-7","article-title":"Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study","volume":"15","author":"Ohlmeier","year":"2015","journal-title":"BMC public health"},{"key":"10.1016\/j.ejvs.2019.12.034_bib19","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"key":"10.1016\/j.ejvs.2019.12.034_bib20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2019.12.034_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2019.12.034_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2019.12.034_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A\u00a0modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"issue":"6 Suppl","key":"10.1016\/j.ejvs.2019.12.034_bib24","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/MLR.0b013e3181d991c4","article-title":"A\u00a0framework for evidence evaluation and methodological issues in implantable device studies","volume":"48","author":"Sedrakyan","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2019.12.034_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2019.12.034_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2019.12.034_bib27","article-title":"Is paclitaxel causing mortality during lower-extremity revascularization?","volume":"8","author":"Swaminathan","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2019.12.034_bib28","first-page":"139","article-title":"Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials","volume":"94","author":"Anantha-Narayanan","year":"2019","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.12.034_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2019.12.034_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.12.034_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2019.12.034_bib32","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2019.12.034_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejvs.2018.06.001","article-title":"The strengths and limitations of claims based research in countries with fee for service reimbursement","volume":"56","author":"Behrendt","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2019.12.034_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1676","article-title":"Comparing long-term mortality after carotid endarterectomy vs carotid stenting using a novel instrumental variable method for risk adjustment in observational time-to-event data","volume":"1","author":"Columbo","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejvs.2019.12.034_bib35","doi-asserted-by":"crossref","first-page":"37177","DOI":"10.1038\/srep37177","article-title":"Stent revascularization versus bypass surgery for peripheral artery disease in type 2 diabetic patients \u2013 an instrumental variable analysis","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858841932708X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858841932708X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:54:21Z","timestamp":1761047661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858841932708X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S107858841932708X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.12.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737189742.793569504","asserted-by":"object"}]},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2019.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}